`

Final Rules

  • New Animal Drugs Afoxalaner Ceftiofur Crystalline Free Acid Chloramine-T Clodronate Enrofloxacin Eprinomectin Fluralaner Ivermectin and Praziquantel Niclosamide Ractopamine Tylosin Change of Sponsors Address
  • Patient Protection and Affordable Care Act; Program Integrity: Exchange, Premium Stabilization Programs, and Market Standards; Amendments to the HHS Notice of Benefit and Payment Parameters for 2014; Correcting Amendment
  • Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2015; Correcting Amendment
  • Ninety-Day Waiting Period Limitation
  • Guidance for Industry Demonstration of the Quality Factor Requirements for Eligible Infant Formulas; Availability
  • Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements
  • Maximum Civil Money Penalty Amounts; Civil Money Penalty Complaints; Confirmation of Effective Date
  • Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act
  • Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions
  • General and Plastic Surgery Devices: Reclassification of Ultraviolet Lamps for Tanning, Henceforth To Be Known as Sunlamp Products and Ultraviolet Lamps Intended for Use in Sunlamp Products
  • Microbiology Devices; Reclassification of Nucleic Acid-Based Systems for Mycobacterium tuberculosis Complex in Respiratory Specimens
  • Administrative Detention of Drugs Intended for Human or Animal Use
  • Medicare Program; Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs
  • Patient Protection and Affordable Care Act; Exchange and Insurance Market Standards for 2015 and Beyond
  • Food Additives Permitted for Direct Addition to Food for Human Consumption; Advantame
  • Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review, Technical Amendment
  • Medicare and Medicaid Programs; Regulatory Provisions To Promote Program Efficiency, Transparency, and Burden Reduction; Part II
  • Prospective Payment System for Federally Qualified Health Centers; Changes to Contracting Policies for Rural Health Clinics; and Changes to Clinical Laboratory Improvement Amendments of 1988 Enforcement Actions for Proficiency Testing Referral
  • Medicare Program; FY 2014 Hospice Wage Index and Payment Rate Update; Hospice Quality Reporting Requirements; and Updates on Payment Reform; Final Rule
  • Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, DME Face-to-Face Encounters, Elimination of the Requirement for Termination of Non-Random Prepayment Complex Medical Review and Other Revisions to Part B for CY 2013; Final
Showing 381 to 400 of 426 results
<< < 18 19 20 21 22 >

Which Codify by AAPC tool is right for you?

Call 844-334-2816 to speak with a Codify by AAPC specialist now.